A regulatory take on cannabis and cannabinoids for medicinal use in the European Union

1European Monitoring Centre for Drugs and Drug Addiction. Medical use of cannabis and cannabinoids: questions and answers for policymaking. Luxembourg: Publications Office of the European Union; 2018 [displayed 22 March 2019]. Available at http://www.emcdda.europa.eu/publications/rapid-communications/medical-use-of-cannabis-and-cannabinoids-questions-and-answers-for-policymaking_en European Monitoring Centre for Drugs and Drug Addiction. Medical use of cannabis and cannabinoids: questions and answers for policymaking Luxembourg Publications Office of the European Union 2018 [displayed 22 March 2019]. Available at http://www.emcdda.europa.eu/publications/rapid-communications/medical-use-of-cannabis-and-cannabinoids-questions-and-answers-for-policymaking_enSearch in Google Scholar

2Congressional Research Service. Report R44742. Defining Hemp: A Fact Sheet [displayed 22 March 2019]. Available at https://crsreports.congress.gov Congressional Research Service. Report R44742. Defining Hemp A Fact Sheet [displayed 22 March 2019 Available at https://crsreports.congress.govSearch in Google Scholar

3Zuardi AW. History of cannabis as a medicine: A review. Rev Bras Psiquiatr 2006;28:153–7. doi: 10.1590/S1516-44462006000200015 Zuardi AW History of cannabis as a medicine: A review Rev Bras Psiquiatr 200628153 7 10.1590/S1516-44462006000200015Open DOISearch in Google Scholar

4Abuhasira R, Shbiro L, Landschaft Y. Medical use of cannabis and cannabinoids containing products - Regulations in Europe and North America. Eur J Intern Med 2018;49:2–6. doi: 10.1016/j.ejim.2018.01.001 Abuhasira R Shbiro L Landschaft Y Medical use of cannabis and cannabinoids containing products - Regulations in Europe and North America Eur J Intern Med 2018492 6 10.1016/j.ejim.2018.01.00129329891Open DOISearch in Google Scholar

5Grinspoon L, Bakalar J. Marihuana: The Forbidden Medicine. New Haven: Yale University Press; 1997. Grinspoon L Bakalar J Marihuana: The Forbidden Medicine New Haven Yale University Press; 1997Search in Google Scholar

6Di Marzo V. New approaches and challenges to targeting the endocannabinoid system. Nat Rev Drug Discov 2018;17:623–39. doi: 10.1038/nrd.2018.115 Di Marzo V New approaches and challenges to targeting the endocannabinoid system Nat Rev Drug Discov 201817623 39 10.1038/nrd.2018.11530116049Open DOISearch in Google Scholar

7Ferjan I, Kržan M, Lipnik-Štangelj M, Žiberna L, Stanovnik L, Černe K. Farmakologija kanabinoidov. Zdrav Vestn 2015;84:456–71 [displayed 22 March 2019]. Available at https://www.dlib.si/stream/URN:NBN:SI:DOC-KYQQTGWH/08a52892-59b7-40b8-9da3-6a9b38f289d8/PDF Ferjan I Kržan M Lipnik-Štangelj M Žiberna L Stanovnik L Černe K Farmakologija kanabinoidov Zdrav Vestn 201584456 71 [displayed 22 March 2019]. Available at https://www.dlib.si/stream/URN:NBN:SI:DOC-KYQQTGWH/08a52892-59b7-40b8-9da3-6a9b38f289d8/PDF10.6016/ZdravVestn.1360Search in Google Scholar

8Fine PG, Rosenfeld MJ. The endocannabinoid system, cannabinoids, and pain. Rambam Maimonides Med J 2013;4(4):e0022. doi: 10.5041/RMMJ.10129 Fine PG Rosenfeld MJ The endocannabinoid system, cannabinoids, and pain Rambam Maimonides Med J 201344e0022 10.5041/RMMJ.10129382029524228165Open DOISearch in Google Scholar

9Andre CM, Hausman JF, Guerriero G. Cannabis sativa: The plant of the thousand and one molecules. Front Plant Sci 2016;7:19. doi: 10.3389/fpls.2016.00019 Andre CM Hausman JF Guerriero G Cannabis sativa The plant of the thousand and one molecules Front Plant Sci 2016719 10.3389/fpls.2016.00019474039626870049Open DOISearch in Google Scholar

10Panlilio LV, Goldberg SR, Justinova Z. Cannabinoid abuse and addiction: Clinical and preclinical findings. Clin Pharmacol Ther 2015;97:616–27. doi: 10.1002/cpt.118 Panlilio LV Goldberg SR Justinova Z Cannabinoid abuse and addiction: Clinical and preclinical findings Clin Pharmacol Ther 201597616 27 10.1002/cpt.118444618625788435Open DOISearch in Google Scholar

11Mulalić E, Sollner Dolenc M. Synthetic cannabinoids. In: Drev A, editor. Report on the drug situation 2015 of the Republic of Slovenia. Ljubljana: Inštitut za varovanje zdravja; 2015. p. 21–2 [displayed 22 March 2019]. Available at http://www.nijz.si/sites/www.nijz.si/files/publikacije-datoteke/nr_2015_f.pdf Mulalić E Sollner Dolenc M Synthetic cannabinoids In Drev A editor Report on the drug situation 2015 of the Republic of Slovenia Ljubljana Inštitut za varovanje zdravja; 2015 p 21–2 [displayed 22 March 2019]. Available at http://www.nijz.si/sites/www.nijz.si/files/publikacije-datoteke/nr_2015_f.pdfSearch in Google Scholar

12Sutlović D, Prkačin I, Vaiano F, Bertol E, Veršić Bratinčević M, Definis-Gojanović M. A case of synthetic cannabinoid poisoning in Croatia. Arh Hig Rada Toksikol 2018;69:186–90. doi: 10.2478/aiht-2018-69-3100 Sutlović D Prkačin I Vaiano F Bertol E Veršić Bratinčević M Definis-Gojanović M A case of synthetic cannabinoid poisoning in Croatia Arh Hig Rada Toksikol 201869186 90 10.2478/aiht-2018-69-310029990295Open DOISearch in Google Scholar

13Vučinić S, Kilibarda V, Đorđević S, Đorđević D, Perković Vukčević N, Vuković-Ercegović G, Antonijević B, Ćurčić M, Antonijević E, Brajković G. Clinical and analytical experience of the National Poison Control Centre with synthetic cannabinoids. Arh Hig Rada Toksikol 2018;69:178– 85. doi: 10.2478/aiht-2018-69-3096 Vučinić S Kilibarda V Đorđević S Đorđević D Perković Vukčević N Vuković-Ercegović G Antonijević B Ćurčić M Antonijević E Brajković G Clinical and analytical experience of the National Poison Control Centre with synthetic cannabinoids Arh Hig Rada Toksikol 201869178–85 10.2478/aiht-2018-69-309629990297Open DOISearch in Google Scholar

14European Monitoring Centre for Drugs and Drug Addiction. Cannabis legislation in Europe: an overview. Luxembourg: Publications Office of the European Union; 2018 [displayed 22 March 2019]. Available at http://www.emcdda.europa.eu/publications/adhoc/cannabis-legislation-europe_en European Monitoring Centre for Drugs and Drug Addiction. Cannabis legislation in Europe: an overview Luxembourg Publications Office of the European Union; 2018 [displayed 22 March 2019]. Available at http://www.emcdda.europa.eu/publications/adhoc/cannabis-legislation-europe_enSearch in Google Scholar

15United Nations Office on Drugs and Crime (UNODC). Single Convention on Narcotic Drugs, 1961 [displayed 22 March 2019]. Available at https://www.unodc.org/unodc/en/treaties/single-convention.html United Nations Office on Drugs and Crime (UNODC). Single Convention on Narcotic Drugs 1961 [displayed 22 March 2019]. Available at https://www.unodc.org/unodc/en/treaties/single-convention.htmlSearch in Google Scholar

16Danenberg E, Sorge L, Wieniawski W, Elliott S, Amato L, Scholten W. Modernizing methodology for the WHO assessment of substances for the international drug control conventions. Drug Alcohol Depend 2013;131:175–81. doi: 10.1016/j.drugalcdep.2013.02.032 Danenberg E Sorge L Wieniawski W Elliott S Amato L Scholten W Modernizing methodology for the WHO assessment of substances for the international drug control conventions Drug Alcohol Depend 2013131175 81 10.1016/j.drugalcdep.2013.02.03223548737Open DOISearch in Google Scholar

17United Nations Office on Drugs and Crime (UNODC). Convention on Psychotropic Substances, 1971 [displayed 22 March 2019]. Available at https://www.unodc.org/unodc/en/treaties/psychotropics.html United Nations Office on Drugs and Crime (UNODC). Convention on Psychotropic Substances, 1971 [displayed 22 March 2019] Available at https://www.unodc.org/unodc/en/treaties/psychotropics.htmlSearch in Google Scholar

18United Nations Office on Drugs and Crime (UNODC). United Nations Convention against Illicit Traffic in Narcotic Drugs and Psychotropic Substances, 1988 [displayed 22 March 2019]. Available at https://www.unodc.org/unodc/en/treaties/illicit-trafficking.html United Nations Office on Drugs and Crime (UNODC). United Nations Convention against Illicit Traffic in Narcotic Drugs and Psychotropic Substances 1988 [displayed 22 March 2019]. Available at https://www.unodc.org/unodc/en/treaties/illicit-trafficking.htmlSearch in Google Scholar

19Aizpurua-Olaizola O, Elezgarai I, Rico-Barrio I, Zarandona I, Etxebarria N, Usobiaga A. Targeting the endocannabinoid system: future therapeutic strategies. Drug Discovery Today 2017;22:105–10. doi: 10.1016/j.drudis.2016.08.005 Aizpurua-Olaizola O Elezgarai I Rico-Barrio I Zarandona I Etxebarria N Usobiaga A Targeting the endocannabinoid system: future therapeutic strategies Drug Discovery Today 201722105 10 10.1016/j.drudis.2016.08.00527554802Open DOISearch in Google Scholar

20National Academies of Sciences, Engineering, and Medicine. The health effects of cannabis and cannabinoids: the current state of evidence and recommendations for research. Washington (DC): The National Academies Press; 2017. doi: 10.17226/24625 National Academies of Sciences, Engineering, and Medicine. The health effects of cannabis and cannabinoids: the current state of evidence and recommendations for research Washington (DC) The National Academies Press 2017 10.17226/2462528182367Open DOISearch in Google Scholar

21Directive 2001/83/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to medicinal products for human use [displayed 22 March 2019]. Available at https://eur-lex.europa.eu/eli/dir/2001/83/oj Directive 2001/83/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to medicinal products for human use [displayed 22 March 2019] Available at https://eur-lex.europa.eu/eli/dir/2001/83/ojSearch in Google Scholar

22European Medicines Agency. Orphan designation: Cannabidiol for: the treatment of Dravet syndrome [displayed 22 March 2019]. Available at https://www.ema.europa.eu/en/medicines/human/orphan-designations/eu3141339 European Medicines Agency. Orphan designation: Cannabidiol for: the treatment of Dravet syndrome [displayed 22 March 2019 Available at https://www.ema.europa.eu/en/medicines/human/orphan-designations/eu3141339Search in Google Scholar

23European Medicines Agency. Epidyolex. EPAR [displayed 22 March 2019]. Available at https://www.ema.europa.eu/en/medicines/human/EPAR/epidyolex European Medicines Agency. Epidyolex EPAR [displayed 22 March 2019 Available at https://www.ema.europa.eu/en/medicines/human/EPAR/epidyolexSearch in Google Scholar

24Electronic Medicines Compendium (EMC). Sativex Oromucosal Spray. SmPC, 2018 [displayed 22 March 2019]. Available at https://www.medicines.org.uk/emc/product/602/smpc Electronic Medicines Compendium (EMC). Sativex Oromucosal Spray SmPC 2018 [displayed 22 March 2019]. Available at https://www.medicines.org.uk/emc/product/602/smpcSearch in Google Scholar

25Danish Medicines Agency. Medicinal use of Cannabis, 3^rd ed. Copenhagen: Medicines Control & Inspection; 2015. File no.2013113424/ [displayed 22 March 2019]. Available at https://laegemiddelstyrelsen.dk/en/news/2015/updated-memo-on-medicinal-use-of-cannabis/~/media/CA79D52432AC4045A999C6C183FB173B.ashx Danish Medicines Agency. Medicinal use of Cannabis, 3^rd ed Copenhagen Medicines Control & Inspection; 2015 File no.2013113424/ [displayed 22 March 2019]. Available at https://laegemiddelstyrelsen.dk/en/news/2015/updated-memo-on-medicinal-use-of-cannabis/~/media/CA79D52432AC4045A999C6C183FB173B.ashxSearch in Google Scholar

26Drugs.com Cesamet [displayed 22 February 2020]. Available at https://www.drugs.com/cesamet.html Drugs.com Cesamet [displayed 22 February 2020 Available at https://www.drugs.com/cesamet.htmlSearch in Google Scholar

27Álvares M. After legalisation, what next for medical cannabis in Portugal? Health Europa [displayed 30 January 2020]. Available at https://www.healtheuropa.eu/medical-cannabis-in-portugal/90986/ Álvares M After legalisation, what next for medical cannabis in Portugal? Health Europa [displayed 30 January 2020 Available at https://www.healtheuropa.eu/medical-cannabis-in-portugal/90986/Search in Google Scholar

28Státní agentura pro konopí pro léčebné použití (SAKL). 236/2015 Coll. Decree of 4 September 2015 stipulating the conditions of prescribing, preparation, distribution, dispensing, and use of magistral formulas containing medical cannabis [cited 2019 May 5]. Available at http://www.sakl.cz/assets/user/Decree%20No%20236-2015.pdf Státní agentura pro konopí pro léčebné použití (SAKL). 236/2015 Coll. Decree of 4 September 2015 stipulating the conditions of prescribing, preparation, distribution, dispensing, and use of magistral formulas containing medical cannabis [cited 2019 May 5] Available at http://www.sakl.cz/assets/user/Decree%20No%20236-2015.pdfSearch in Google Scholar

29Federal Institute for Drugs and Medical Devices. Annual Report 2017/2018. Bonn: Federal Institute for Drugs and Medical Devices, 2018 [displayed 22 March 2019]. Available at https://www.bfarm.de/SharedDocs/Downloads/EN/BfArM/Publikationen/AnnualReport2017-18.pdf?__blob=publicationFile&v=4 Federal Institute for Drugs and Medical Devices. Annual Report 2017/2018 Bonn Federal Institute for Drugs and Medical Devices 2018 [displayed 22 March 2019]. Available at https://www.bfarm.de/SharedDocs/Downloads/EN/BfArM/Publikationen/AnnualReport2017-18.pdf?__blob=publicationFile&v=4Search in Google Scholar

30Office of Medicinal Cannabis. Medicinal cannabis. The Hague: Institute for Responsible Medicine Use and the Office of Medicinal Cannabis of the CIBG, 2011 [displayed 22 March 2019]. Available at https://english.cannabisbureau.nl/medicinal-cannabis Office of Medicinal Cannabis. Medicinal cannabis The Hague Institute for Responsible Medicine Use and the Office of Medicinal Cannabis of the CIBG 2011 [displayed 22 March 2019]. Available at https://english.cannabisbureau.nl/medicinal-cannabisSearch in Google Scholar

31Regulation (EU) 2015/2283 of the European Parliament and of the Council of 25 November 2015 on novel foods, amending Regulation (EU) No 1169/2011 of the European Parliament and of the Council and repealing Regulation (EC) No 258/97 of the European Parliament and of the Council and Commission Regulation (EC) No 1852/2001 [displayed 22 March 2019]. Available at https://eur-lex.europa.eu/eli/reg/2015/2283/oj Regulation (EU) 2015/2283 of the European Parliament and of the Council of 25 November 2015 on novel foods, amending Regulation (EU) No 1169/2011 of the European Parliament and of the Council and repealing Regulation (EC) No 258/97 of the European Parliament and of the Council and Commission Regulation (EC) No 1852/2001 [displayed 22 March 2019] Available at https://eur-lex.europa.eu/eli/reg/2015/2283/ojSearch in Google Scholar

32Deutscher Arzenimittel-Codex Neues Rezeptur-Formularium. Cannabis [displayed 22 February 2020]. Available at https://dacnrf.pharmazeutische-zeitung.de/index.php?id=suchen Deutscher Arzenimittel-Codex Neues Rezeptur-Formularium Cannabis [displayed 22 February 2020 Available at https://dacnrf.pharmazeutische-zeitung.de/index.php?id=suchenSearch in Google Scholar

33Zakon o lekarniški dejavnosti [Pharmacy Practice Act, in Slovenian]. Uradni list RS, št. 85/16 [displayed 22 February 2020]. Available at http://www.pisrs.si/Pis.web/pregledPredpisa?id=ZAKO7375 Zakon o lekarniški dejavnosti [Pharmacy Practice Act, in Slovenian] Uradni list RS, št 8516 [displayed 22 February 2020 Available at http://www.pisrs.si/Pis.web/pregledPredpisa?id=ZAKO7375Search in Google Scholar

34Čufar A. Regulatorni vidik predpisovanja kanabinoidov [Prescribing of cannabinoids – a regulatory view, in Slovenian]. Farm Vestn 2016;67:91-6. Čufar A Regulatorni vidik predpisovanja kanabinoidov [Prescribing of cannabinoids – a regulatory view, in Slovenian] Farm Vestn 20166791 6Search in Google Scholar

35World Health Organization (WHO). WHO guidelines on good agricultural and collection practices (GACP) for medicinal plants. Geneva: WHO; 2003 [displayed 22 March 2019]. Available at http://apps.who.int/medicinedocs/pdf/s4928e/s4928e.pdf World Health Organization (WHO). WHO guidelines on good agricultural and collection practices (GACP) for medicinal plants Geneva WHO 2003 [displayed 22 March 2019]. Available at http://apps.who.int/medicinedocs/pdf/s4928e/s4928e.pdfSearch in Google Scholar

36European Medicines Agency. Guidelines on Good Agricultural and Collection Practices ( GACP) for starting materials of herbal origin, 2006 Feb. EMEA/ HMPC/246816/2005 [displayed 22 March 2019]. Available at https://www.ema.europa.eu/en/documents/scientific-guideline/guideline-good-agricultural-collection-practice-gacp-starting-materials-herbal-origin_en.pdf European Medicines Agency. Guidelines on Good Agricultural and Collection Practices ( GACP) for starting materials of herbal origin 2006 Feb. EMEA/ HMPC/246816/2005 [displayed 22 March 2019]. Available at https://www.ema.europa.eu/en/documents/scientific-guideline/guideline-good-agricultural-collection-practice-gacp-starting-materials-herbal-origin_en.pdfSearch in Google Scholar

37Malta Medicines Authority. General Guidelines on the Production of cannabis for medicinal and research purposes, 2018 Dec. Ref No: GL-CAN01/01 [displayed 22 March 2019]. Available at http://www.medicinesauthority.gov.mt Malta Medicines Authority. General Guidelines on the Production of cannabis for medicinal and research purposes 2018 Dec. Ref No: GL-CAN01/01 [displayed 22 March 2019]. Available at http://www.medicinesauthority.gov.mtSearch in Google Scholar

38Manifava D. Greece grants country’s first medical cannabis licenses, 2018 [displayed 22 March 2019]. Availble at http://www.ekathimerini.com/234842/article/ekathimerini/news/greece-grants-countrys-first-medical-cannabis-licenses Manifava D Greece grants country’s first medical cannabis licenses 2018 [displayed 22 March 2019]. Availble at http://www.ekathimerini.com/234842/article/ekathimerini/news/greece-grants-countrys-first-medical-cannabis-licensesSearch in Google Scholar

39Nanaimo B.C. Tilray® Increases International Export Capacity with New Outdoor Cultivation Site in Portugal, 2019 [displayed 22 March 2019]. Available at https://www.tilray.com/tilraynews-master/2019/8/7/tilray-increases-international-export-capacity-with-new-outdoor-cultivation-site-in-portugal Nanaimo B.C Tilray® Increases International Export Capacity with New Outdoor Cultivation Site in Portugal 2019 [displayed 22 March 2019]. Available at https://www.tilray.com/tilraynews-master/2019/8/7/tilray-increases-international-export-capacity-with-new-outdoor-cultivation-site-in-portugalSearch in Google Scholar

40Agency for Medicinal Products and Medical Devices of the Republic of Slovenia. Andreja Čufar. Stališče JAZMP v zvezi s predlogom o spremembi razvrstitve konoplje in ureditvi gojenja konoplje [JAZMP’s position on the proposal to amend the classification of cannabis and the regulation of cannabis cultivation, in Slovenian] [displayed 30 January 2020]. Available at https://www.jazmp.si/fileadmin/datoteke/dokumenti/Stalisce_JAZMP_glede_konoplje.pdf Agency for Medicinal Products and Medical Devices of the Republic of Slovenia. Andreja Čufar. Stališče JAZMP v zvezi s predlogom o spremembi razvrstitve konoplje in ureditvi gojenja konoplje [JAZMP’s position on the proposal to amend the classification of cannabis and the regulation of cannabis cultivation, in Slovenian] [displayed 30 January 2020] Available at https://www.jazmp.si/fileadmin/datoteke/dokumenti/Stalisce_JAZMP_glede_konoplje.pdfSearch in Google Scholar

41Publications Office of the EU. C/2017/4132 Common catalogue of varieties of agricultural plant species - fifth supplement to the 35^th complete edition. Avilable at: https://op.europa.eu/en/publication-detail/-/publication/3d31e818-5715-11e7-a5ca-01aa75ed71a1 Publications Office of the EU. C/2017/4132 Common catalogue of varieties of agricultural plant species - fifth supplement to the 35^th complete edition Avilable at https://op.europa.eu/en/publication-detail/-/publication/3d31e818-5715-11e7-a5ca-01aa75ed71a1Search in Google Scholar

42European Commission. EU Novel food catalogue. Available at: http://ec.europa.eu/food/safety/novel_food/catalogue/search/public/?event=home&seqfce=72&ascii= European Commission. EU Novel food catalogue Available at http://ec.europa.eu/food/safety/novel_food/catalogue/search/public/?event=home&seqfce=72&ascii=Search in Google Scholar